| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.43▲ | 1.44▼ | 1.45▼ | 1.49▼ | 1.60▼ |
| MA10 | 1.44▼ | 1.46▼ | 1.47▼ | 1.53▼ | 1.74▼ |
| MA20 | 1.46▼ | 1.48▼ | 1.49▼ | 1.60▼ | 1.85▼ |
| MA50 | 1.49▼ | 1.50▼ | 1.52▼ | 1.77▼ | 2.25▼ |
| MA100 | 1.50▼ | 1.55▼ | 1.59▼ | 1.86▼ | 2.93▼ |
| MA200 | 1.53▼ | 1.62▼ | 1.71▼ | 2.13▼ | 6.43▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.004▼ | -0.005▼ | -0.008▼ | -0.024▼ |
| RSI | 30.797▼ | 29.891▼ | 28.521▼ | 25.993▼ | 34.169▼ |
| STOCH | 6.667▼ | 2.564▼ | 1.961▼ | 6.161▼ | 4.187▼ |
| WILL %R | -75.000▼ | -88.235▼ | -89.474▼ | -93.750▼ | -98.214▼ |
| CCI | -89.939 | -113.076▼ | -145.153▼ | -125.772▼ | -133.743▼ |
|
Thursday, March 12, 2026 05:17 AM
Sabrina Martucci Johnson, President and CEO of Daré Bioscience, discusses FDA clearance of the IND for DARE-HPV, the planned Phase 2 clinical study, and what the program could mean for women’s ...
|
|
Thursday, March 05, 2026 04:41 AM
Pre-Fulfillment Prescribing Now Available in All 50 States, Supporting National LaunchDeveloped and evaluated specifically for women, DARE to PLAY™ Sildenafil Cream is a first-of-its-kind female ...
|
|
Sunday, February 22, 2026 11:59 PM
SAN DIEGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/03/26 | 1.50 | 1.51 | 1.42 | 1.44 | 72,689 |
| 12/03/26 | 1.5275 | 1.5299 | 1.47 | 1.48 | 28,681 |
| 11/03/26 | 1.51 | 1.54 | 1.49 | 1.50 | 38,162 |
| 10/03/26 | 1.54 | 1.55 | 1.49 | 1.49 | 32,862 |
| 09/03/26 | 1.55 | 1.55 | 1.50 | 1.53 | 73,297 |
| 06/03/26 | 1.58 | 1.58 | 1.52 | 1.53 | 57,324 |
| 05/03/26 | 1.61 | 1.61 | 1.56 | 1.57 | 47,194 |
| 04/03/26 | 1.57 | 1.59 | 1.56 | 1.56 | 47,108 |
| 03/03/26 | 1.61 | 1.61 | 1.56 | 1.565 | 77,236 |
| 02/03/26 | 1.6699 | 1.6813 | 1.58 | 1.61 | 120,574 |
|
|
||||
|
|
||||
|
|